These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 29636108)
1. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. Li S; Ma YM; Zheng PS; Zhang P J Exp Clin Cancer Res; 2018 Apr; 37(1):80. PubMed ID: 29636108 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression. Zhao TC; Zhou ZH; Ju WT; Liang SY; Tang X; Zhu DW; Zhang ZY; Zhong LP Cancer Sci; 2022 Feb; 113(2):478-488. PubMed ID: 34826159 [TBL] [Abstract][Full Text] [Related]
3. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways. Li Y; Cui N; Zheng PS; Yang WT Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase. Gesmundo I; Di Blasio L; Banfi D; Villanova T; Fanciulli A; Favaro E; Gamba G; Musuraca C; Rapa I; Volante M; Munegato S; Papotti M; Gontero P; Primo L; Ghigo E; Granata R Cancer Lett; 2019 May; 449():252-262. PubMed ID: 30790678 [TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells. Joshi JP; Brown NE; Griner SE; Nahta R Biochem Pharmacol; 2011 Nov; 82(9):1090-9. PubMed ID: 21803025 [TBL] [Abstract][Full Text] [Related]
6. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. Bai L; Mao R; Wang J; Ding L; Jiang S; Gao C; Kang H; Chen X; Sun X; Xu J Med Oncol; 2015 Mar; 32(3):57. PubMed ID: 25647783 [TBL] [Abstract][Full Text] [Related]
7. Folate receptor alpha is associated with cervical carcinogenesis and regulates cervical cancer cells growth by activating ERK1/2/c-Fos/c-Jun. Liu C; Ding L; Bai L; Chen X; Kang H; Hou L; Wang J Biochem Biophys Res Commun; 2017 Sep; 491(4):1083-1091. PubMed ID: 28782518 [TBL] [Abstract][Full Text] [Related]
8. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression. Cui N; Yang WT; Zheng PS Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045 [TBL] [Abstract][Full Text] [Related]
9. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells]. Liu Y; Chen X; Luo Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280 [TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells. Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737 [TBL] [Abstract][Full Text] [Related]
11. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107 [TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling. Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1. Bhowmik T; Gomes A Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Liu X; Li G Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770 [TBL] [Abstract][Full Text] [Related]
15. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells. Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794 [TBL] [Abstract][Full Text] [Related]
16. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation. Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710 [TBL] [Abstract][Full Text] [Related]
17. Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation. Okamoto M; Koma YI; Kodama T; Nishio M; Shigeoka M; Yokozaki H Pathobiology; 2020; 87(2):100-113. PubMed ID: 31896114 [TBL] [Abstract][Full Text] [Related]
19. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways. Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma. Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]